Monte Rosa Therapeutics, Inc.Monte Rosa Therapeutics, Inc.Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc.

No trades
See on Supercharts

GLUE fundamentals

Monte Rosa Therapeutics, Inc. earnings per share and revenue

GLUE earnings per share for the last quarter are 0.57 USD whereas the estimation was -0.00 USD which accounts for 21674.56% surprise. Company revenue for the same period amounts to 84.93 M USD despite the estimated figure of 41.68 M USD. Estimated earnings per share for the next quarter are -0.38 USD, and revenue is expected to reach 7.38 M USD. Also watch annual changes over time to get a bigger picture of GLUE earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise